Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Sun Pharma gets USFDA nod for generic diabetes tablets
Zee News, India
Sat, 07/13/13 - 12:43 pm
Tags:
Sun Pharma, diabetes, repaglinide, Prandin, Novo Nordisk, generics
China's Coming Big Pharma Boom
Motley Fool
Wed, 07/10/13 - 11:07 am
Tags:
China, Big Pharma, Merck, Novo Nordisk, Bayer, Pfizer, Teva
Merck's $5.7 Billion Diabetes Franchise Is Vulnerable
Seeking Alpha
Wed, 07/10/13 - 10:25 am
Tags:
Merck, diabetes, Novo Nordisk, Eli Lilly, Novartis, Januvia
Dissecting the World's Biggest Diabetes Drug Stock
Motley Fool
Sat, 07/6/13 - 11:56 am
Tags:
Novo Nordisk
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Tags:
Novo Nordisk, diabetes, Eli Lilly, GLP-1 agonist, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Victoza
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thu, 06/27/13 - 08:55 pm
Tags:
Eli Lilly, diabetes, dulaglutide, JNJ, Merck, Novo Nordisk, Bristol-Myers Squibb
Novo Nordisk Suspends Paula Deen As A Spokesperson
Pharmalot
Thu, 06/27/13 - 11:15 am
Tags:
Novo Nordisk, Paula Deen, diabetes
New AMA Obesity Ruling Should Push Big Pharma To Find Acquisitions
Seeking Alpha
Thu, 06/27/13 - 09:59 am
Tags:
obesity, M&A, Oramed, AstraZeneca, MannKind, Merck, Sanofi, Novo Nordisk
New GSK diabetes drug works, but faces tough competition
Reuters
Mon, 06/24/13 - 10:28 am
Tags:
GSK, diabetes, albiglutide, GLP-1 agonist, Victoza, Byetta, Bydureon, Novo Nordisk, Bristol-Myers Squibb, AstraZeneca
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Fri, 06/21/13 - 09:26 am
Tags:
diabetes, Merck, Januvia, Lantus, Sanofi, NovoRapid, Novo Nordisk, Eli Lilly, Humalog, Victoza, Levemir, Janumet, Novo Mix 30, Takeda, Actos
Novo Nordisk shares hit by concerns over rival diabetes drugs
Reuters
Mon, 06/17/13 - 09:17 am
Tags:
diabetes, Novo Nordisk, Sanofi, Eli Lilly, dulaglutide, Victoza, Lyxumia, Lantus
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
Tags:
FDA, diabetes, Merck, Januvia, Onglyza, Bristol-Myers Squibb, Byetta, AstraZeneca, Eli Lilly, Novo Nordisk, Victoza, Tradjenta, Boehringer Ingelheim
Novo Nordisk Is An Undervalued Industry Leading Healthcare Company
Seeking Alpha
Wed, 06/12/13 - 08:53 am
Tags:
Novo Nordisk
Sanofi steps up diabetes drive as rivals raise the stakes
Reuters
Fri, 06/7/13 - 09:18 am
Tags:
Sanofi, diabetes, Novo Nordisk
Novo Nordisk Has One of the Widest Moats in Health Care
Yahoo/Morningstar
Thu, 06/6/13 - 10:04 am
Tags:
Novo Nordisk, diabetes
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
Tags:
physicians, diabetes, Bristol-Myers Squibb, Byetta, Merck, AstraZeneca, Januvia, Novo Nordisk, Eli Lilly, Takeda, Boehringer Ingelheim
Is Novo A Threat To Arena, Vivus, And Orexigen?
Seeking Alpha
Thu, 05/30/13 - 09:02 am
Tags:
obesity, Novo Nordisk, Victoza, Arena Pharmaceuticals, Vivus, Orexigen
Novo obesity drug could launch in U.S. end 2014
Reuters
Fri, 05/24/13 - 10:40 am
Tags:
Novo Nordisk, liraglutide, obesity, weight loss
Positive Data on Novo Nordisk's N9-GP
Yahoo/Zacks
Wed, 05/22/13 - 09:41 am
Tags:
Novo Nordisk, N9-GP, hemophilia B
Novo Nordisk completes PhIII hemophilia trial with positive results
Fierce Biotech
Fri, 05/17/13 - 12:01 pm
Tags:
Novo Nordisk, hemophilia B, N9-GP

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.